1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol
C23H26ClN5O3 — CID 118881330
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol
1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol (PubChem CID 118881330) has the molecular formula C23H26ClN5O3 and a molecular weight of 455.95 g/mol. Its IUPAC name is 1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol.
Molecular Properties
| Compound Name | 1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol |
|---|---|
| PubChem CID | 118881330 |
| Molecular Formula | C23H26ClN5O3 |
| Molecular Weight | 455.95 g/mol |
| Exact Mass | 455.17 |
| IUPAC Name | 1-[3-chloro-5-(4-morpholin-4-yl-6-pyridin-4-ylpyrimidin-2-yl)phenoxy]-3-(methylamino)propan-2-ol |
| SMILES | CNCC(O)COc1cc(Cl)cc(-c2nc(-c3ccncc3)cc(N3CCOCC3)n2)c1 |
| InChI | InChI=1S/C23H26ClN5O3/c1-25-14-19(30)15-32-20-11-17(10-18(24)12-20)23-27-21(16-2-4-26-5-3-16)13-22(28-23)29-6-8-31-9-7-29/h2-5,10-13,19,25,30H,6-9,14-15H2,1H3 |
| InChIKey | NFUXMHAMVXNKGQ-UHFFFAOYSA-N |
| XLogP | 2.65 |
| TPSA | 92.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.95 |
| LogP ≤ 5 | 2.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118881330 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.